Positron emission tomography/computed tomography (PET/CT) using radiotracers that bind to the prostate-specific membrane antigen (PSMA) is mainly used in biochemical recurrence (BCR) of prostate cancer (PCa). This evidence concerns the gene FOLH1 and prostate carcinoma.